CCR5 and metabolic dysfunction-associated steatotic liver disease: It activates T cell proliferation and cytokine production, contributing to inflammatory responses, hepatic fibrosis, and early stages of metabolic dysfunction-associated steatotic liver disease (MASLD) by inducing steatosis through the Ccr5 receptor57,58.